PAYX Form 4: 725-share RSU award and 3,061-share option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Paychex (PAYX) Form 4: A director reported equity awards on 10/15/2025. The filing shows an award of 725 shares of common stock at a price of $0, noted as restricted stock units subject to vesting. Following this, 889 shares were beneficially owned directly, and 23,758 shares were beneficially owned indirectly through the Joseph G. Doody Revocable Living Trust. A stock option for 3,061 shares was granted at an exercise price of $127.52, first exercisable on 10/15/2026 and expiring on 10/14/2035.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
DOODY JOSEPH
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 3,061 | $127.52 | $390K |
| Grant/Award | Common Stock | 725 | $0.00 | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Common Stock - Family Trust | -- | -- | -- |
Holdings After Transaction:
Stock Option — 3,061 shares (Direct);
Common Stock — 889 shares (Direct);
Common Stock - Family Trust — 23,758 shares (Indirect, Joseph G. Doody Revocable Living Trust)
Footnotes (1)
- [object Object]
FAQ
What did PAYX report in this Form 4?
A director reported an award of 725 common shares (as RSUs subject to vesting) and a new stock option for 3,061 shares.
What is the exercise price and term of the new option at PAYX?
The option covers 3,061 shares at $127.52, first exercisable on 10/15/2026 and expiring on 10/14/2035.
Does the PAYX Form 4 include other outstanding options?
Yes. The table lists additional outstanding stock options with various exercise prices and expiration dates.